tm logo
Harbinger Health
SEARCHED

on 27 Feb 2024

Last Applicant/ Owned by

Harbinger Health, Inc.

55 Cambridge Parkway, Suite 800ECambridge MA 02142

US

Serial Number

2300355 filed on 03rd Apr 2023

Correspondent Address

550 Burrard Street, Suite 1900Vancouver

BRITISH COLUMBIA

CA

V6C3A8

Harbinger Health

Vienna Information


24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 7

Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

27 . 1 . 1

Letters or numerals forming geometrical figures, written or typographical matter in perspectiveLettres ou chiffres formant des figures géométriques, inscriptions en perspective

27 . 1 . 2

Letters or numerals forming a square or a rectangle (surface or periphery)Lettres ou chiffres formant un carré ou un rectangle (surface ou pourtour)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Trademark usage description

pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagno Read More

Classification Information


Class [005]
Pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer; pharmaceutical preparations comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer.


Classification kind code

12

Class [042]
Scientific research, namely, biochemical research, conducting research in the field of new pharmaceuticals, and scientific research for medical purposes in the fields of cancer, cancer treatment, cancer prevention, and cancer diagnosis, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals.


Classification kind code

12

Mark Details


Serial Number

2300355

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 256
on 21st Oct 2024
Notification of Possible Opposition Sent
Submitted for opposition 48
on 04th Apr 2024
Agent Changed
Submitted for opposition 22
on 27th Feb 2024
Search Recorded
Submitted for opposition 20
on 27th Feb 2024
Examiner's First Report
Submitted for opposition 223
on 27th Feb 2024
Total Provisional Refusal
Submitted for opposition 257
on 21st Dec 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 20th Dec 2023
Formalized
Submitted for opposition 1
on 20th Dec 2023
Created
Submitted for opposition 228
on 03rd Apr 2023
International Registration
Submitted for opposition 30
on 03rd Apr 2023
Filed